A detailed history of Green Alpha Advisors, LLC transactions in Invitae Corp stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 450,148 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
450,148
Previous 452,585 0.54%
Holding current value
$0
Previous $285,000 98.6%
% of portfolio
0.0%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$0.01 - $0.61 $24 - $1,486
-2,437 Reduced 0.54%
450,148 $4,000
Q4 2023

Jan 04, 2024

BUY
$0.42 - $0.72 $110,359 - $189,187
262,760 Added 138.42%
452,585 $285,000
Q3 2023

Oct 10, 2023

SELL
$0.6 - $1.53 $29,980 - $76,449
-49,967 Reduced 20.84%
189,825 $113,000
Q2 2023

Jul 06, 2023

BUY
$1.05 - $1.63 $28,339 - $43,993
26,990 Added 12.68%
239,792 $270,000
Q1 2023

Apr 06, 2023

BUY
$1.2 - $2.73 $87,892 - $199,956
73,244 Added 52.48%
212,802 $287,000
Q4 2022

Jan 12, 2023

SELL
$1.71 - $3.61 $42,635 - $90,008
-24,933 Reduced 15.16%
139,558 $0
Q3 2022

Oct 14, 2022

SELL
$1.9 - $8.63 $632,658 - $2.87 Million
-332,978 Reduced 66.93%
164,491 $405,000
Q2 2022

Jul 08, 2022

BUY
$2.13 - $9.01 $883,019 - $3.74 Million
414,563 Added 500.04%
497,469 $1.21 Million
Q1 2022

Apr 19, 2022

BUY
$6.28 - $15.59 $273,537 - $679,053
43,557 Added 110.69%
82,906 $661,000
Q4 2021

Jan 12, 2022

SELL
$14.7 - $28.67 $235,523 - $459,350
-16,022 Reduced 28.94%
39,349 $601,000
Q3 2021

Oct 12, 2021

BUY
$24.31 - $33.6 $152,642 - $210,974
6,279 Added 12.79%
55,371 $1.57 Million
Q2 2021

Jul 22, 2021

BUY
$26.09 - $40.4 $900,757 - $1.39 Million
34,525 Added 237.01%
49,092 $1.66 Million
Q1 2021

Jul 22, 2021

BUY
$33.06 - $56.93 $297,573 - $512,426
9,001 Added 161.71%
14,567 $557,000
Q4 2020

Jul 22, 2021

BUY
$39.09 - $57.4 $217,574 - $319,488
5,566 New
5,566 $233,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.